{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:02Z","timestamp":1787013902872,"version":"build-2736575974"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T00:00:00Z","timestamp":1427068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      The incidence of adverse drug events (\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      ) in surgical and non\u2010surgical patients may differ. This individual patient data meta\u2010analysis (\n                      <jats:styled-content style=\"fixed-case\">IPDMA<\/jats:styled-content>\n                      ) identifies patient characteristics and types of medication most associated with patients experiencing\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      and suggests target areas for reducing harm and implementing focused interventions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Authors of eligible studies on preventable\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">pADEs<\/jats:styled-content>\n                      ) were approached for collaboration. For assessment of differences among (non\u2010)surgical patients and identification of associated factors descriptive statistics,\n                      <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                      earson chi\u2010square, Poisson and logistic regression analyses were performed. For identification of high risk drugs (\n                      <jats:styled-content style=\"fixed-case\">HRDs<\/jats:styled-content>\n                      ), a model was developed based on frequency, severity and preventability of medication related to\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Included were 5367 patients from four studies. Patients aged \u2265 77 years experienced more\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">pADEs<\/jats:styled-content>\n                      compared with patients aged \u2264 52 years (odds ratios (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      ) 2.12 (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.70, 2.65) and 2.55 (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.70, 3.84), respectively, both\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05). Polypharmacy on admission also increased the risk of\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      1.21 (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.03, 1.44),\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05) and\n                      <jats:styled-content style=\"fixed-case\">pADEs<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      1.85 (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.34, 2.56),\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05).\n                      <jats:styled-content style=\"fixed-case\">pADEs<\/jats:styled-content>\n                      were associated with more severe harm than non\u2010preventable\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      (54%\n                      <jats:italic>vs<\/jats:italic>\n                      . 32%,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.05). The top five\n                      <jats:styled-content style=\"fixed-case\">HRDs<\/jats:styled-content>\n                      were antibiotics, sedatives, anticoagulants, diuretics and antihypertensives. Events associated with\n                      <jats:styled-content style=\"fixed-case\">HRDs<\/jats:styled-content>\n                      included diarrhoea or constipation, abnormal liver function test and central nervous system events. Most\n                      <jats:styled-content style=\"fixed-case\">pADEs<\/jats:styled-content>\n                      resulted from prescribing errors (90%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Elderly patients with polypharmacy on admission and receiving antibiotics, sedatives, anticoagulants, diuretics or antihypertensives were more prone to experiencing\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      . Efficiency in prevention of\n                      <jats:styled-content style=\"fixed-case\">ADEs<\/jats:styled-content>\n                      may be improved by targeted vigilance systems for alertness of physicians and pharmacists.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bcp.12504","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T06:02:02Z","timestamp":1410242522000},"page":"548-557","source":"Crossref","is-referenced-by-count":26,"title":["An individual patient data meta\u2010analysis on factors associated with adverse drug events in surgical and non\u2010surgical inpatients"],"prefix":"10.1111","volume":"79","author":[{"given":"Eveline B.","family":"Boeker","sequence":"first","affiliation":[{"name":"Department of Surgery Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Ram","sequence":"additional","affiliation":[{"name":"Department of Surgery Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Klopotowska","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse Tuset","family":"Creus","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy Hospital Clinic  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L.","family":"de Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy Hospital Clinic  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine Hyogo College of Medicine  Nishinomiya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine Hyogo College of Medicine  Nishinomiya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja A.","family":"Boermeester","sequence":"additional","affiliation":[{"name":"Department of Surgery Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G. W.","family":"Dijkgraaf","sequence":"additional","affiliation":[{"name":"Clinical Research Unit Academic Medical Center  Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,23]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"To Err Is Human: Building A Safer Health System","author":"Kohn LT","year":"1999"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-311X2009001500003"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02698.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730050-00003"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa0911535"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2006.019273"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2005.015107"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00145.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9941-x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-013-9797-5"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1316-4"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/17.3.261"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00411-0"},{"key":"e_1_2_9_15_1","unstructured":"National Cancer Institute.Common Terminology Criteria for Adverse Events v.3.0and v.4.0 (CTCAE). [Internet]. Available athttp:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm(last accessed 18 December 2012)."},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1130-6343(09)72974-5"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1518-3"},{"key":"e_1_2_9_19_1","unstructured":"GriffinF ResarR.IHI global trigger tool for measuring adverse events (second edition). IHI Innov. Ser. White Pap.2009. Available atwww.IHI.org(last accessed 18 December 2012)."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzt075"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.21.2553"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa020703"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02600138"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.13.1629"},{"key":"e_1_2_9_25_1","first-page":"537","article-title":"Preventing harm from high\u2010alert medications","volume":"33","author":"Federico F","year":"2007","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2012-000946"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002036"},{"key":"e_1_2_9_28_1","unstructured":"Agency for Healthcare Research and Quality RockvilleM.Reducing and preventing adverse drug events to decrease hospital costs: research in action. Issue 1.2001. Available athttp:\/\/www.ahrq.gov\/research\/findings\/factsheets\/errors\u2010safety\/aderia\/index.html(last accessed 18 December 2012)."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12033"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7174.2010.00058.x"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12504","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T01:06:41Z","timestamp":1696295201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,23]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1111\/bcp.12504"],"URL":"https:\/\/doi.org\/10.1111\/bcp.12504","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,23]]}}}